The percutaneous introduction of idarucizumab dabigatran reversal ...

[gonzo233]

The percutaneous introduction of idarucizumab dabigatran reversal agent into a peripheral vein, new technology group1 is reported with code _____.
 a. XW01331 b. XW04331
  c. XW03321 d. XW03331

Question 2

The putting in, or putting on, of a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance, except blood or blood products, is known as _____.
 a. medication management b. narcosynthesis
  c. introduction
  d. infusion

[Heffejeff]

Answer to Question 1

d

Answer to Question 2

c

[gonzo233]

Thanks for the timely response, appreciate it

[peter]

Excellent